The article discusses the significant impact of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) on global health, particularly in HIV treatment. The freeze on foreign aid initiated by the Trump administration threatens ongoing support for this initiative, essential in saving 25 million lives since 2003. With PEPFAR's annual costs being less than 0.1% of the national budget, its contributions span public health and global economic growth. While a waiver was announced to continue HIV-drug distribution, the broader aspects of PEPFAR's services, like health worker education, remain uncertain.
The Trump administration's freeze on foreign aid jeopardizes the future of the U.S. President's Emergency Plan for AIDS Relief, a program that saved 25 million lives.
PEPFAR, launched in 2003, has improved public health in over 50 countries, distributing HIV drugs at a cost of less than 0.1% of the national budget.
Collection
[
|
...
]